Kidney Transplant Clinical Trials

45 recruiting

Kidney Transplant Trials at a Glance

148 actively recruiting trials for kidney transplant are listed on ClinicalTrialsFinder across 6 cities in 39 countries. The largest study group is Not Applicable with 43 trials, with the heaviest enrollment activity in Boston, Paris, and New York. Lead sponsors running kidney transplant studies include IRCCS Azienda Ospedaliero-Universitaria di Bologna, Assistance Publique - Hôpitaux de Paris, and Nantes University Hospital.

Browse kidney transplant trials by phase

Treatments under study

About Kidney Transplant Clinical Trials

Looking for clinical trials for Kidney Transplant? There are currently 45 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Kidney Transplant trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Kidney Transplant clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 148 trials

Recruiting
Phase 2

The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients

Kidney Transplant Recipients
University Health Network, Toronto20 enrolled1 locationNCT05938712
Recruiting
Not Applicable

Interventions for Promoting Kidney Transplant Empowerment

Kidney Transplant Waitlisting
Icahn School of Medicine at Mount Sinai5 enrolled3 locationsNCT06655857
Recruiting
Phase 1

Eight-Treg Study:Trial of Adoptive Immunotherapy With Autologous ex Vivo Expanded Regulatory CD8+ T Cells in Living Donor Kidney Transplant Recipients

Kidney Transplantation
Nantes University Hospital9 enrolled1 locationNCT06777719
Recruiting
Not Applicable

Testing the Feasibility of a Self-Management Support Program for Patient With Chronic Diseases in Israel

Cancer SurvivorshipChronic DiseaseKidney Transplantation
University of Haifa45 enrolled1 locationNCT07367750
Recruiting
Phase 3

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

Kidney TransplantDelayed Graft FunctionDGF
Alexion Pharmaceuticals, Inc.450 enrolled130 locationsNCT06830798
Recruiting
Phase 2

REgulatory T Cell Therapy to Achieve Immunosuppression REduction

Kidney Transplantation
Singulera Therapeutics Inc.34 enrolled7 locationsNCT06552169
Recruiting
Phase 2Phase 3

A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

Kidney Transplant Rejection
Sanofi526 enrolled10 locationsNCT07412470
Recruiting
Phase 2

Imlifidase Prior to Kidney Transplant in Highly Sensitised Children

Kidney Transplantation in Highly Sensitized Patients
Hansa Biopharma AB10 enrolled5 locationsNCT05753930
Recruiting
Not Applicable

Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program

ObesityKidney Transplant; Complications
Virginia Commonwealth University30 enrolled1 locationNCT06688825
Recruiting
Phase 4

Empagliflozin Treatment in Kidney Transplant Recipients

Kidney TransplantChronic Kidney Disease
VA Office of Research and Development264 enrolled5 locationsNCT06013865
Recruiting
Early Phase 1

CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants

Highly Sensitized Patients Awaiting Kidney Transplant
Tongji Hospital12 enrolled1 locationNCT07350837
Recruiting

The Mycophenolate Pregnancy Registry

Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases
Genentech, Inc.500 enrolled1 locationNCT01733082
Recruiting

Observational Single-center Study of the Relationship Between Arterial Hypertension and Hypervolemia Defined by Self-measurement of Impedancemetry in Kidney Transplant Patients With Transplantation Less Than 6 Months Old

Kidney Transplant Patients
Nantes University Hospital150 enrolled1 locationNCT05039788
Recruiting

Vascular Complications After Kidney Transplantation

Heart FailureKidney Transplant; ComplicationsRenovascular Hypertension+4 more
University of Aarhus60 enrolled3 locationsNCT07531966
Recruiting
Phase 2

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

Kidney Transplant; Complications
University of North Carolina, Chapel Hill100 enrolled1 locationNCT06059664
Recruiting
Not Applicable

Diode Laser-Assisted Periodontal Therapy in Kidney Transplant Recipients

PeriodontitisKidney Transplant Recipients
Military Hospital 10380 enrolled2 locationsNCT07532694
Recruiting

Personalized Stories for Pediatric Kidney Recipients

Kidney Transplant
Paris Translational Research Center for Organ Transplantation100 enrolled1 locationNCT07532382
Recruiting
Not Applicable

Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage

Chronic Kidney Disease (Stages 4 and 5)Kidney Transplantation RecipientsEnd Stage Chronic Renal Failure
Vanderbilt University Medical Center30 enrolled1 locationNCT07385651
Recruiting
Phase 3

Shingrix in Renal Transplant Recipients

Kidney FailureKidney TransplantationKidney Failure, Chronic+2 more
University of Colorado, Denver132 enrolled4 locationsNCT04128189
Recruiting

Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients

Kidney Transplant
Chiesi Poland Sp. z o.o.120 enrolled6 locationsNCT06833463